Biogen Inc.: Biogen to Present New Research at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)
CAMBRIDGE, Mass., March 11, 2022(Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, as well as data for ADUHELM (aducanumab-avwa) injection 100 mg/mL for intravenous use
Source: finanznachrichten.de